Skip to main content
PMC home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;9(3):698–703. doi: 10.1111/j.1582-4934.2005.tb00500.x

Association of refractory complex partial seizures with a polymorphism of ApoE genotype

Davor Sporiš 1,✉, Jadranka Sertic 2, Neven Henigsberg 3, Darija Mahovic 1, Nenad Bogdanovic 4, Tomislav Babic 1
PMCID: PMC6741410  PMID: 16202217

Abstract

Apolipoprotein E (ApoE) is a constituent of many types of lipoproteins that play a role in metabolism of cholesterol and lipids in the body as well as in the brain. ApoE is synthesised in astrocytes and microglia and enter to neurons through LDL, LRP and VLDL receptors. Recently it was shown that ApoE is also produced in neurons. ApoE has a role in modulating learning and memory, structural plasticity, mobilization of cholesterol in repair, growth and maintenance of myelin and neuronal membranes during development and aging, and cell death after ischemic, convulsive, or other type of brain injury. The aim of this research was to investigate the possible association of ApoE gene polymorphism with the development of resistance to pharmacological therapy in patients with partial complex seizures with or without secondary generalization. In this prospective matched‐pair controlled study, 60 patients with cryptogenic epilepsy with complex partial seizures, with or without secondary generalization, who have been suffering for five or more years, were studied. The first group comprised 30 patients refractory to the current therapy, while the second group consisted of patients with well‐controlled seizures. The refractory and non‐refractory groups of patients differed significantly in their phenotypes. Phenotype E3/4 was six times more frequent in refractory group than among non‐refractory group. The lack of response was shown to be significantly associated with the presence of β allele. This study provided evidence that the presence of β4 allele is more often associated with a lack of response to current antiepileptic drugs as compared to β2 and β3 alleles.

Keywords: ApoE polymorphism, refractory epilepsy, complex partial seizures, ischaemia/reperfusion, non‐responders, pharmacotherapy

References

  • 1. Meldrum BS. Anatomy, physiology, and pathology of epilepsy. Lancet 1990; 336: 231–4. [DOI] [PubMed] [Google Scholar]
  • 2. Cedazo‐Minguez A, Cowburn RF. Apolipoprotein E: a major piece in the Alzheimer's disease puzzle. J Cell Mol Med. 2001; 5: 254–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Beffert U Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Rev. 1998; 27: 119–42. [DOI] [PubMed] [Google Scholar]
  • 4. Weisgraber KH, Mahley RW. Human apolipoprotein E: the Alzheimer, disease connection. FASEB J. 1996; 10: 1485–94. [DOI] [PubMed] [Google Scholar]
  • 5. Smith JD. Apolipoprotein E4: an allele associated with many diseases. Ann Med. 2000; 32: 118–27. [DOI] [PubMed] [Google Scholar]
  • 6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak‐Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–3. [DOI] [PubMed] [Google Scholar]
  • 7. McCarron MO, DeLong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease. Neurology 1999; 53: 1308–11. [DOI] [PubMed] [Google Scholar]
  • 8. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral haemorrhage (letter). Lancet 1995; 346: 575. [DOI] [PubMed] [Google Scholar]
  • 9. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Yehuda B, Groswasser Z. Apolipoproteine E?4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 1999; 52: 244–8. [DOI] [PubMed] [Google Scholar]
  • 10. Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek‐Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD. APOE genotype is a major predictor of long‐term progression of disability in MS. Neurology 2001; 56: 312–6. [DOI] [PubMed] [Google Scholar]
  • 11. Montpied P, de Bock F, Lerner‐Natoli M, Bockaert J, Rondouin G. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Epilepsy Res. 1999; 35: 135–46. [DOI] [PubMed] [Google Scholar]
  • 12. Taylor WJ, Diers MH. A Textbook for clinical application of therapeutic drug monitoring, Abbott Laboratories Diagnostics Irving, Texas. 1986.
  • 13. Oertel R, Richter K, Gramatte T, Kirch W. Determination of drugs in biological fluids by high‐perfomance liquid chromatography with on‐line sample processing. J Chromatog A. 1998; 797: 203–9. [DOI] [PubMed] [Google Scholar]
  • 14. Hixson JE, Borenstein L, Cox LA, Rainwater DL, Vander Berg JL. The baboon gene for apolipoprotein A‐I: characterization of a cDNA clone and identification of DNA polymorphisms for genetic studies of cholesterol metabolism. Gene 1988; 74: 483–490. [DOI] [PubMed] [Google Scholar]
  • 15. Hixon JE, Wernier DT. Restriction isotyping of human apolipoprotein E by gene aplification and eleavage with Hhal. J Lipid Res. 1990; 31: 545–8. [PubMed] [Google Scholar]
  • 16. Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss‐Coray T, Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 2000; 97: 207–10. [DOI] [PubMed] [Google Scholar]
  • 17. Toescu EC, Verkhratsky A. Ca2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med. 2004; 8: 181–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Verkhratsky A, Toescu EC. Endoplasmic reticulum Ca2+ homeostasis and neuronal death. J Cell Mol Med. 2003; 7: 351–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Casetta I, Granieri E, Monneti VC, Gilli G, Tola MR, Paolino E, Govoni V, Iezzi E. Early predictors of intractability in childhood epilepsy: a community‐based case‐control study in Copparo, Italy. Acta Neurol Scan. 1999; 99: 329–33. [DOI] [PubMed] [Google Scholar]
  • 20. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry. 2001; 70: 240–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000; 48: 833–41. [PubMed] [Google Scholar]
  • 22. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM. Association of multidrug resistance in epilepsy with a polymorphism in the drug‐transporter gene ABCB1. N Engl J Med. 2003; 348: 1442–8. [DOI] [PubMed] [Google Scholar]
  • 23. Kilpatric ES, Jagger CE, Spooner RJ, Brodie MJ. Apolipoprotein E and epilepsy. Ann Clin Biochem. 1996; 33: 146–7. [DOI] [PubMed] [Google Scholar]
  • 24. Gambardella A, Aguglia U, Cittadella R, Romeo N, Sibilia G, LePiane E, Messina D, Manna I, Oliveri RL, Zappia M, Quattrone A. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999; 40: 1804–7. [DOI] [PubMed] [Google Scholar]
  • 25. Yeni SN, Ozkara C, Buyru N, Baykara O, Hanoglu L, Karaagac N, Ozyurt E, Uzan M. Association between APOE polymorphism and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur J Neurol. 2005; 12: 103–7. [DOI] [PubMed] [Google Scholar]
  • 26. Diaz‐Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC. Increased risk of late postraumatic seizures associated with inheritance of APOEε4 allele. Arch Neurol. 2003; 60: 818–22. [DOI] [PubMed] [Google Scholar]
  • 27. Briellmann RS, Torn‐Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, Jackson GD, Frauman AG, Berkovic SF. APOE?4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000; 55: 435–7. [DOI] [PubMed] [Google Scholar]
  • 28. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. Increased apolipoprotein Eε4 in epilepsy with senile plaques. Ann Neurology 1997; 41: 402–4. [DOI] [PubMed] [Google Scholar]
  • 29. Gambardella A, Aguglia U, Chifari R, Labate A, Manna I, Serra P, Romeo N, Sibilia G, Lepiane E, Russa AL, Ventura P, Cittadella R, Sasanelli F, Colosimo E, Leggio U, Zappia M, Quattrone A. ApoEε4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia 2005; 46: 110–7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES